Table of Contents
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Competitive landscape
2 Introduction
2.1. What is this report about?
2.2. Who is the target reader?
2.3. How to use this report
2.4. Definitions
3 Global Pharmaceuticals
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 Macroeconomic Indicators
4.1. Country data
5 Pharmaceuticals in Asia-Pacific
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 Pharmaceuticals in Europe
6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis
7 Macroeconomic Indicators
7.1. Country data
8 Pharmaceuticals in France
8.1. Market Overview
8.2. Market Data
8.3. Market Segmentation
8.4. Market outlook
8.5. Five forces analysis
9 Macroeconomic Indicators
9.1. Country data
10 Pharmaceuticals in Germany
10.1. Market Overview
10.2. Market Data
10.3. Market Segmentation
10.4. Market outlook
10.5. Five forces analysis
11 Macroeconomic Indicators
11.1. Country data
12 Pharmaceuticals in Australia
12.1. Market Overview
12.2. Market Data
12.3. Market Segmentation
12.4. Market outlook
12.5. Five forces analysis
13 Macroeconomic Indicators
13.1. Country data
14 Pharmaceuticals in Brazil
14.1. Market Overview
14.2. Market Data
14.3. Market Segmentation
14.4. Market outlook
14.5. Five forces analysis
15 Macroeconomic Indicators
15.1. Country data
16 Pharmaceuticals in Canada
16.1. Market Overview
16.2. Market Data
16.3. Market Segmentation
16.4. Market outlook
16.5. Five forces analysis
17 Macroeconomic Indicators
17.1. Country data
18 Pharmaceuticals in China
18.1. Market Overview
18.2. Market Data
18.3. Market Segmentation
18.4. Market outlook
18.5. Five forces analysis
19 Macroeconomic Indicators
19.1. Country data
20 Pharmaceuticals in India
20.1. Market Overview
20.2. Market Data
20.3. Market Segmentation
20.4. Market outlook
20.5. Five forces analysis
21 Macroeconomic Indicators
21.1. Country data
22 Pharmaceuticals in Indonesia
22.1. Market Overview
22.2. Market Data
22.3. Market Segmentation
22.4. Market outlook
22.5. Five forces analysis
23 Macroeconomic Indicators
23.1. Country data
24 Pharmaceuticals in Italy
24.1. Market Overview
24.2. Market Data
24.3. Market Segmentation
24.4. Market outlook
24.5. Five forces analysis
25 Macroeconomic Indicators
25.1. Country data
26 Pharmaceuticals in Japan
26.1. Market Overview
26.2. Market Data
26.3. Market Segmentation
26.4. Market outlook
26.5. Five forces analysis
27 Macroeconomic Indicators
27.1. Country data
28 Pharmaceuticals in Mexico
28.1. Market Overview
28.2. Market Data
28.3. Market Segmentation
28.4. Market outlook
28.5. Five forces analysis
29 Macroeconomic Indicators
29.1. Country data
30 Pharmaceuticals in The Netherlands
30.1. Market Overview
30.2. Market Data
30.3. Market Segmentation
30.4. Market outlook
30.5. Five forces analysis
31 Macroeconomic Indicators
31.1. Country data
32 Pharmaceuticals in North America
32.1. Market Overview
32.2. Market Data
32.3. Market Segmentation
32.4. Market outlook
32.5. Five forces analysis
33 Pharmaceuticals in Russia
33.1. Market Overview
33.2. Market Data
33.3. Market Segmentation
33.4. Market outlook
33.5. Five forces analysis
34 Macroeconomic Indicators
34.1. Country data
35 Pharmaceuticals in Scandinavia
35.1. Market Overview
35.2. Market Data
35.3. Market Segmentation
35.4. Market outlook
35.5. Five forces analysis
36 Pharmaceuticals in Singapore
36.1. Market Overview
36.2. Market Data
36.3. Market Segmentation
36.4. Market outlook
36.5. Five forces analysis
37 Macroeconomic Indicators
37.1. Country data
38 Pharmaceuticals in South Africa
38.1. Market Overview
38.2. Market Data
38.3. Market Segmentation
38.4. Market outlook
38.5. Five forces analysis
39 Macroeconomic Indicators
39.1. Country data
40 Pharmaceuticals in South Korea
40.1. Market Overview
40.2. Market Data
40.3. Market Segmentation
40.4. Market outlook
40.5. Five forces analysis
41 Macroeconomic Indicators
41.1. Country data
42 Pharmaceuticals in Spain
42.1. Market Overview
42.2. Market Data
42.3. Market Segmentation
42.4. Market outlook
42.5. Five forces analysis
43 Macroeconomic Indicators
43.1. Country data
44 Pharmaceuticals in Turkey
44.1. Market Overview
44.2. Market Data
44.3. Market Segmentation
44.4. Market outlook
44.5. Five forces analysis
45 Macroeconomic Indicators
45.1. Country data
46 Pharmaceuticals in The United Kingdom
46.1. Market Overview
46.2. Market Data
46.3. Market Segmentation
46.4. Market outlook
46.5. Five forces analysis
47 Macroeconomic Indicators
47.1. Country data
48 Pharmaceuticals in The United States
48.1. Market Overview
48.2. Market Data
48.3. Market Segmentation
48.4. Market outlook
48.5. Five forces analysis
49 Macroeconomic Indicators
49.1. Country data
50 Company Profiles
50.1. Bayer AG
50.2. Novartis AG
50.3. Laboratoires Pierre Fabre SA
50.4. Boehringer Ingelheim GmbH
50.5. Ache Laboratorios Farmaceuticos SA
50.6. EMS Sigma Pharma
50.7. Apotex, Inc.
50.8. Yangtze River Pharmaceutical Group
50.9. Shanghai Pharmaceuticals Holding Co Ltd
50.10. Yunnan Baiyao Group Co Ltd
50.11. Guangzhou Pharmaceutical Holdings Ltd
50.12. Sun Pharmaceutical Industries Ltd
50.13. Lupin Ltd
50.14. Dr. Reddy's Laboratories Limited
50.15. Aurobindo Pharma Ltd
50.16. PT Kimia Farma Tbk
50.17. A Menarini Industrie Farmaceutiche Riunite Srl
50.18. Recordati S.p.A.
50.19. Chiesi Farmaceutici SpA
50.20. Daiichi Sankyo Co Ltd
50.21. Takeda Pharmaceutical Company Limited
50.22. Mitsubishi Tanabe Pharma Corporation
50.23. Genomma Lab Internacional SAB de CV
50.24. Les Laboratoires Servier
50.25. F. Hoffmann-La Roche Ltd
50.26. Astellas Pharma Inc.
50.27. Aspen Pharmacare Holdings Ltd
50.28. Adcock Ingram Holdings Ltd
50.29. Chong Kun Dang Pharmaceutical Corp.
50.30. Daewoong Pharmaceutical Co Ltd
50.31. Hanmi Pharmaceuticals Co Ltd
50.32. Almirall S.A.
50.33. Sanofi SA
50.34. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
50.35. GSK plc.
50.36. Johnson & Johnson
50.37. Merck & Co., Inc.
50.38. Pfizer Inc.
50.39. AstraZeneca PLC
51 Appendix
51.1. Methodology
51.2. About MarketLine

List of Tables
Table 1: Global pharmaceuticals market value: $ billion, 2017-22
Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: Global pharmaceuticals market share: % share, by value, 2022
Table 4: Global pharmaceuticals market value forecast: $ billion, 2022–27
Table 5: Global size of population (million), 2018–22
Table 6: Global gdp (constant 2005 prices, $ billion), 2018–22
Table 7: Global gdp (current prices, $ billion), 2018–22
Table 8: Global inflation, 2018–22
Table 9: Global consumer price index (absolute), 2018–22
Table 10: Global exchange rate, 2018–22
Table 11: Asia-Pacific pharmaceuticals market value: $ billion, 2017-22
Table 12: Asia–Pacific pharmaceuticals market geography segmentation: $ billion, 2022
Table 13: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2022–27
Table 14: Europe pharmaceuticals market value: $ billion, 2017-22
Table 15: Europe pharmaceuticals market geography segmentation: $ billion, 2022
Table 16: Europe pharmaceuticals market value forecast: $ billion, 2022–27
Table 17: Europe size of population (million), 2018–22
Table 18: Europe gdp (constant 2005 prices, $ billion), 2018–22
Table 19: Europe gdp (current prices, $ billion), 2018–22
Table 20: Europe inflation, 2018–22
Table 21: Europe consumer price index (absolute), 2018–22
Table 22: Europe exchange rate, 2018–22
Table 23: France pharmaceuticals market value: $ billion, 2017-22
Table 24: France pharmaceuticals market geography segmentation: $ billion, 2022
Table 25: France pharmaceuticals market value forecast: $ billion, 2022–27
Table 26: France size of population (million), 2018–22
Table 27: France gdp (constant 2005 prices, $ billion), 2018–22
Table 28: France gdp (current prices, $ billion), 2018–22
Table 29: France inflation, 2018–22
Table 30: France consumer price index (absolute), 2018–22
Table 31: France exchange rate, 2018–22
Table 32: Germany pharmaceuticals market value: $ billion, 2017-22
Table 33: Germany pharmaceuticals market geography segmentation: $ billion, 2022
Table 34: Germany pharmaceuticals market value forecast: $ billion, 2022–27
Table 35: Germany size of population (million), 2018–22
Table 36: Germany gdp (constant 2005 prices, $ billion), 2018–22
Table 37: Germany gdp (current prices, $ billion), 2018–22
Table 38: Germany inflation, 2018–22
Table 39: Germany consumer price index (absolute), 2018–22
Table 40: Germany exchange rate, 2018–22
Table 41: Australia pharmaceuticals market value: $ billion, 2017-22
Table 42: Australia pharmaceuticals market geography segmentation: $ billion, 2022
Table 43: Australia pharmaceuticals market value forecast: $ billion, 2022–27
Table 44: Australia size of population (million), 2018–22
Table 45: Australia gdp (constant 2005 prices, $ billion), 2018–22
Table 46: Australia gdp (current prices, $ billion), 2018–22
Table 47: Australia inflation, 2018–22
Table 48: Australia consumer price index (absolute), 2018–22
Table 49: Australia exchange rate, 2018–22
Table 50: Brazil pharmaceuticals market value: $ billion, 2017-22
Table 51: Brazil pharmaceuticals market geography segmentation: $ billion, 2022
Table 52: Brazil pharmaceuticals market value forecast: $ billion, 2022–27
Table 53: Brazil size of population (million), 2018–22
Table 54: Brazil gdp (constant 2005 prices, $ billion), 2018–22
Table 55: Brazil gdp (current prices, $ billion), 2018–22
Table 56: Brazil inflation, 2018–22
Table 57: Brazil consumer price index (absolute), 2018–22
Table 58: Brazil exchange rate, 2018–22
Table 59: Canada pharmaceuticals market value: $ billion, 2017-22
Table 60: Canada pharmaceuticals market geography segmentation: $ billion, 2022
Table 61: Canada pharmaceuticals market value forecast: $ billion, 2022–27
Table 62: Canada size of population (million), 2018–22
Table 63: Canada gdp (constant 2005 prices, $ billion), 2018–22
Table 64: Canada gdp (current prices, $ billion), 2018–22
Table 65: Canada inflation, 2018–22
Table 66: Canada consumer price index (absolute), 2018–22
Table 67: Canada exchange rate, 2018–22
Table 68: China pharmaceuticals market value: $ billion, 2017-22
Table 69: China pharmaceuticals market geography segmentation: $ billion, 2022
Table 70: China pharmaceuticals market value forecast: $ billion, 2022–27
Table 71: China size of population (million), 2018–22
Table 72: China gdp (constant 2005 prices, $ billion), 2018–22
Table 73: China gdp (current prices, $ billion), 2018–22
Table 74: China inflation, 2018–22
Table 75: China consumer price index (absolute), 2018–22
Table 76: China exchange rate, 2018–22
Table 77: India pharmaceuticals market value: $ billion, 2017-22
Table 78: India pharmaceuticals market geography segmentation: $ billion, 2022
Table 79: India pharmaceuticals market value forecast: $ billion, 2022–27
Table 80: India size of population (million), 2018–22
Table 81: India gdp (constant 2005 prices, $ billion), 2018–22
Table 82: India gdp (current prices, $ billion), 2018–22
Table 83: India inflation, 2018–22
Table 84: India consumer price index (absolute), 2018–22
Table 85: India exchange rate, 2018–22
Table 86: Indonesia pharmaceuticals market value: $ billion, 2017-22
Table 87: Indonesia pharmaceuticals market geography segmentation: $ billion, 2022
Table 88: Indonesia pharmaceuticals market value forecast: $ billion, 2022–27
Table 89: Indonesia size of population (million), 2018–22
Table 90: Indonesia gdp (constant 2005 prices, $ billion), 2018–22
Table 91: Indonesia gdp (current prices, $ billion), 2018–22
Table 92: Indonesia inflation, 2018–22
Table 93: Indonesia consumer price index (absolute), 2018–22
Table 94: Indonesia exchange rate, 2018–22
Table 95: Italy pharmaceuticals market value: $ billion, 2017-22
Table 96: Italy pharmaceuticals market geography segmentation: $ billion, 2022
Table 97: Italy pharmaceuticals market value forecast: $ billion, 2022–27
Table 98: Italy size of population (million), 2018–22
Table 99: Italy gdp (constant 2005 prices, $ billion), 2018–22
Table 100: Italy gdp (current prices, $ billion), 2018–22
Table 101: Italy inflation, 2018–22
Table 102: Italy consumer price index (absolute), 2018–22
Table 103: Italy exchange rate, 2018–22
Table 104: Japan pharmaceuticals market value: $ billion, 2017-22
Table 105: Japan pharmaceuticals market geography segmentation: $ billion, 2022

List of Figures
Figure 1: Global pharmaceuticals market value: $ billion, 2017-22
Figure 2: Global pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 3: Global pharmaceuticals market share: % share, by value, 2022
Figure 4: Global pharmaceuticals market value forecast: $ billion, 2022–27
Figure 5: Forces driving competition in the global pharmaceuticals market, 2022
Figure 6: Drivers of buyer power in the global pharmaceuticals market, 2022
Figure 7: Drivers of supplier power in the global pharmaceuticals market, 2022
Figure 8: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2022
Figure 9: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2022
Figure 10: Drivers of degree of rivalry in the global pharmaceuticals market, 2022
Figure 11: Asia-Pacific pharmaceuticals market value: $ billion, 2017-22
Figure 12: Asia–Pacific pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 13: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2022–27
Figure 14: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2022
Figure 15: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2022
Figure 16: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2022
Figure 17: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2022
Figure 18: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2022
Figure 19: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2022
Figure 20: Europe pharmaceuticals market value: $ billion, 2017-22
Figure 21: Europe pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 22: Europe pharmaceuticals market value forecast: $ billion, 2022–27
Figure 23: Forces driving competition in the pharmaceuticals market in Europe, 2022
Figure 24: Drivers of buyer power in the pharmaceuticals market in Europe, 2022
Figure 25: Drivers of supplier power in the pharmaceuticals market in Europe, 2022
Figure 26: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2022
Figure 27: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2022
Figure 28: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2022
Figure 29: France pharmaceuticals market value: $ billion, 2017-22
Figure 30: France pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 31: France pharmaceuticals market value forecast: $ billion, 2022–27
Figure 32: Forces driving competition in the pharmaceuticals market in France, 2022
Figure 33: Drivers of buyer power in the pharmaceuticals market in France, 2022
Figure 34: Drivers of supplier power in the pharmaceuticals market in France, 2022
Figure 35: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2022
Figure 36: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2022
Figure 37: Drivers of degree of rivalry in the pharmaceuticals market in France, 2022
Figure 38: Germany pharmaceuticals market value: $ billion, 2017-22
Figure 39: Germany pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 40: Germany pharmaceuticals market value forecast: $ billion, 2022–27
Figure 41: Forces driving competition in the pharmaceuticals market in Germany, 2022
Figure 42: Drivers of buyer power in the pharmaceuticals market in Germany, 2022
Figure 43: Drivers of supplier power in the pharmaceuticals market in Germany, 2022
Figure 44: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2022
Figure 45: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2022
Figure 46: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2022
Figure 47: Australia pharmaceuticals market value: $ billion, 2017-22
Figure 48: Australia pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 49: Australia pharmaceuticals market value forecast: $ billion, 2022–27
Figure 50: Forces driving competition in the pharmaceuticals market in Australia, 2022
Figure 51: Drivers of buyer power in the pharmaceuticals market in Australia, 2022
Figure 52: Drivers of supplier power in the pharmaceuticals market in Australia, 2022
Figure 53: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Australia, 2022
Figure 54: Factors influencing the threat of substitutes in the pharmaceuticals market in Australia, 2022
Figure 55: Drivers of degree of rivalry in the pharmaceuticals market in Australia, 2022
Figure 56: Brazil pharmaceuticals market value: $ billion, 2017-22
Figure 57: Brazil pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 58: Brazil pharmaceuticals market value forecast: $ billion, 2022–27
Figure 59: Forces driving competition in the pharmaceuticals market in Brazil, 2022
Figure 60: Drivers of buyer power in the pharmaceuticals market in Brazil, 2022
Figure 61: Drivers of supplier power in the pharmaceuticals market in Brazil, 2022
Figure 62: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2022
Figure 63: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2022
Figure 64: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2022
Figure 65: Canada pharmaceuticals market value: $ billion, 2017-22
Figure 66: Canada pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 67: Canada pharmaceuticals market value forecast: $ billion, 2022–27
Figure 68: Forces driving competition in the pharmaceuticals market in Canada, 2022
Figure 69: Drivers of buyer power in the pharmaceuticals market in Canada, 2022
Figure 70: Drivers of supplier power in the pharmaceuticals market in Canada, 2022
Figure 71: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Canada, 2022
Figure 72: Factors influencing the threat of substitutes in the pharmaceuticals market in Canada, 2022
Figure 73: Drivers of degree of rivalry in the pharmaceuticals market in Canada, 2022
Figure 74: China pharmaceuticals market value: $ billion, 2017-22
Figure 75: China pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 76: China pharmaceuticals market value forecast: $ billion, 2022–27
Figure 77: Forces driving competition in the pharmaceuticals market in China, 2022
Figure 78: Drivers of buyer power in the pharmaceuticals market in China, 2022
Figure 79: Drivers of supplier power in the pharmaceuticals market in China, 2022
Figure 80: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2022
Figure 81: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2022
Figure 82: Drivers of degree of rivalry in the pharmaceuticals market in China, 2022
Figure 83: India pharmaceuticals market value: $ billion, 2017-22
Figure 84: India pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 85: India pharmaceuticals market value forecast: $ billion, 2022–27
Figure 86: Forces driving competition in the pharmaceuticals market in India, 2022
Figure 87: Drivers of buyer power in the pharmaceuticals market in India, 2022
Figure 88: Drivers of supplier power in the pharmaceuticals market in India, 2022
Figure 89: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2022
Figure 90: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2022
Figure 91: Drivers of degree of rivalry in the pharmaceuticals market in India, 2022
Figure 92: Indonesia pharmaceuticals market value: $ billion, 2017-22